Search Results
Dr. Brufsky Discusses Reasons to Use Biosimilars in Oncology
Dr. Brufsky on Biosimilars Being Explored in Oncology
Dr. Brufsky Discusses Biosimilar Development and Approval
The Complexity of Choosing Biosimilars in Oncology
Dr. Brufsky on Challenges Facing Biosimilars in Breast Cancer
Dr. Brufsky on Trastuzumab Biosimilars in Breast Cancer
Dr. Litton Discusses the Potential Advantage of Using Biosimilars in Oncology
Dr. Brufsky Advises Doctors on Bevacizumab for Breast Cancer
Dr. Verma Discusses Challenges With Biosimilars in Oncology
Dr. Brufsky on Challenges in Breast Cancer
Biosimilar Trastuzumab
Dr. Brufsky on Ways to Mitigate Cost Before Biosimilars Reach US Market